TY  - JOUR
AU  - Stojsavljević, Aleksandar
AU  - Jagodić, Jovana
AU  - Pavlović, Slađan
AU  - Dinčić, Evica
AU  - Kuveljić, Jovana
AU  - Manojlović, Dragan
AU  - Živković, Maja
PY  - 2024
UR  - https://vinar.vin.bg.ac.rs/handle/123456789/12937
AB  - Background  Multiple sclerosis (MS) is a chronic demyelinating disorder intricately linked to perturbations in trace element levels. While previous studies have explored circulating trace elements in a limited sample, understanding the impact of demographic and clinical variables on the elemental profile within a larger cohort remains elusive. Methods  This study aimed to evaluate essential trace elements (Cr, Mn, Co, Cu, Zn, and Se) in the sera of 215 MS patients compared to a meticulously matched control group of 100 individuals with similar gender and age. Our main objective was to identify potential variations in elemental profiles based on demographic and clinical parameters among MS patients, elucidating the prospective relevance of supplementing specific essential trace elements. Results  Data indicated a significant decrease in serum levels of Mn, Co, Zn, and Se, and an increase in Cr in MS patients compared to controls. These trace elements not only discriminated between MS patients and controls but also exhibited distinctive capabilities among demographic subgroups. Gender, smoking habits, and age strata (20-40 years and 41-60 years) revealed discernible variations in elemental profiles between MS patients and their control counterparts. Se demonstrated the singular ability to stratify cases of extreme MS severity, mild relapsing-remitting MS (RRMS) and highly severe secondary progressive MS (SPMS). In contrast, Co significantly differentiated RRMS from primary progressive MS (PPMS), while Cu significantly differentiated SPMS from PPMS. Additionally, Cu showed a negative correlation with MSSS, while Mn and Zn showed a positive correlation with EDSS. Conclusion  These findings underscore a substantive deficiency in Mn, Co, Zn, and Se in the MS cohort, supporting targeted supplementation with these trace elements. This study provides a comprehensive understanding of the intricate relationship between essential trace elements and MS, paving the way for further research into personalized nutritional interventions for this complex neurological disorder.
T2  - Journal of Trace Elements in Medicine and Biology
T1  - Essential trace element levels in multiple sclerosis: bridging demographic and clinical gaps, assessing the need for supplementation
VL  - 83
SP  - 127421
DO  - 10.1016/j.jtemb.2024.127421
ER  - 

@article{
author = "Stojsavljević, Aleksandar and Jagodić, Jovana and Pavlović, Slađan and Dinčić, Evica and Kuveljić, Jovana and Manojlović, Dragan and Živković, Maja",
year = "2024",
abstract = "Background  Multiple sclerosis (MS) is a chronic demyelinating disorder intricately linked to perturbations in trace element levels. While previous studies have explored circulating trace elements in a limited sample, understanding the impact of demographic and clinical variables on the elemental profile within a larger cohort remains elusive. Methods  This study aimed to evaluate essential trace elements (Cr, Mn, Co, Cu, Zn, and Se) in the sera of 215 MS patients compared to a meticulously matched control group of 100 individuals with similar gender and age. Our main objective was to identify potential variations in elemental profiles based on demographic and clinical parameters among MS patients, elucidating the prospective relevance of supplementing specific essential trace elements. Results  Data indicated a significant decrease in serum levels of Mn, Co, Zn, and Se, and an increase in Cr in MS patients compared to controls. These trace elements not only discriminated between MS patients and controls but also exhibited distinctive capabilities among demographic subgroups. Gender, smoking habits, and age strata (20-40 years and 41-60 years) revealed discernible variations in elemental profiles between MS patients and their control counterparts. Se demonstrated the singular ability to stratify cases of extreme MS severity, mild relapsing-remitting MS (RRMS) and highly severe secondary progressive MS (SPMS). In contrast, Co significantly differentiated RRMS from primary progressive MS (PPMS), while Cu significantly differentiated SPMS from PPMS. Additionally, Cu showed a negative correlation with MSSS, while Mn and Zn showed a positive correlation with EDSS. Conclusion  These findings underscore a substantive deficiency in Mn, Co, Zn, and Se in the MS cohort, supporting targeted supplementation with these trace elements. This study provides a comprehensive understanding of the intricate relationship between essential trace elements and MS, paving the way for further research into personalized nutritional interventions for this complex neurological disorder.",
journal = "Journal of Trace Elements in Medicine and Biology",
title = "Essential trace element levels in multiple sclerosis: bridging demographic and clinical gaps, assessing the need for supplementation",
volume = "83",
pages = "127421",
doi = "10.1016/j.jtemb.2024.127421"
}

Stojsavljević, A., Jagodić, J., Pavlović, S., Dinčić, E., Kuveljić, J., Manojlović, D.,& Živković, M.. (2024). Essential trace element levels in multiple sclerosis: bridging demographic and clinical gaps, assessing the need for supplementation. in Journal of Trace Elements in Medicine and Biology, 83, 127421.
https://doi.org/10.1016/j.jtemb.2024.127421

Stojsavljević A, Jagodić J, Pavlović S, Dinčić E, Kuveljić J, Manojlović D, Živković M. Essential trace element levels in multiple sclerosis: bridging demographic and clinical gaps, assessing the need for supplementation. in Journal of Trace Elements in Medicine and Biology. 2024;83:127421.
doi:10.1016/j.jtemb.2024.127421 .

Stojsavljević, Aleksandar, Jagodić, Jovana, Pavlović, Slađan, Dinčić, Evica, Kuveljić, Jovana, Manojlović, Dragan, Živković, Maja, "Essential trace element levels in multiple sclerosis: bridging demographic and clinical gaps, assessing the need for supplementation" in Journal of Trace Elements in Medicine and Biology, 83 (2024):127421,
https://doi.org/10.1016/j.jtemb.2024.127421 . .

TY  - CONF
AU  - Stanković, Aleksandra
AU  - Jovanović, Ivan G.
AU  - Dinčić, E.
AU  - Vojinović, S.
AU  - Stojković, Ljiljana S.
AU  - Đorđević, Ana
AU  - Kuveljić, Jovana
AU  - Živković, Maja
PY  - 2023
UR  - https://web.archive.org/web/20240131090652/https://cony2023.comtecmed.com/e-posters/
UR  - https://vinar.vin.bg.ac.rs/handle/123456789/12641
AB  - Molecular background and biomarkers of highly heterogenous and hardly predictable disease progression among relapse-onset MS patients are of high research interest. In the current pilot study, we aimed to employ next-generation sequencing to investigate the expression of whole small non-coding microRNAs (miRNome) in two groups of MS patients with highly distinctive progression phenotype: one with fast progressing, severely disabling course vs. mild course of MS, longitudinally followed 10 years. Peripheral blood mononuclear cells (PBMC) miRNome data was obtained from mild phenotype MS (n=4 patients) and progressive phenotype MS (n=5 patients), using TakaraBio SMARTer smRNA-Seq Kit on iSeq100 (Illumina). Pre-processing of raw sequencing data, quality control and miRNA differential expression analysis was performed using sRNAtoolbox pipeline. Functional interpretation of differentially expressed miRNA target genes was done in DIANA-miRPathv3.0. Tarbase v8.0 served as a resource of miRNA:gene interactions. Achieved read depth was approximately 1 million raw reads/sample, allowing detection of up to 92 mature miRNAs after genome alignment and miRbase v22 annotation. Differential expression analysis identified the significant upregulation of hsa-miR-23c (log2FC=4.29, Padj= 0.03) in progressive phenotype. Top significantly enriched KEGG pathways in hsa-miR-23c targets suggested regulation of molecular pathways involved in autoimmunity (antigen presentation, Epstein-Barr virus infection) and cancer. In conclusion, this pilot study indicates phenotype-related differences in expression of miRNAs, molecules with high regulatory and biomarker properties. Although detected in PBMC, has-miR-23c is highly expressed in the brain and target MS relevant genes such as, HLA (A, B, C), transferrin receptor, Nrf2, recently proposed to play important role in neurodegeneration.
C3  - 17th World Congress on Controversies in Neurology (CONy) : e-posters
T1  - Insight in miRNome of severe multiple sclerosis: Pilot study of distinctive relapse-onset MS phenotypes
SP  - 427
EP  - 427
UR  - https://hdl.handle.net/21.15107/rcub_vinar_12641
ER  - 

@conference{
author = "Stanković, Aleksandra and Jovanović, Ivan G. and Dinčić, E. and Vojinović, S. and Stojković, Ljiljana S. and Đorđević, Ana and Kuveljić, Jovana and Živković, Maja",
year = "2023",
abstract = "Molecular background and biomarkers of highly heterogenous and hardly predictable disease progression among relapse-onset MS patients are of high research interest. In the current pilot study, we aimed to employ next-generation sequencing to investigate the expression of whole small non-coding microRNAs (miRNome) in two groups of MS patients with highly distinctive progression phenotype: one with fast progressing, severely disabling course vs. mild course of MS, longitudinally followed 10 years. Peripheral blood mononuclear cells (PBMC) miRNome data was obtained from mild phenotype MS (n=4 patients) and progressive phenotype MS (n=5 patients), using TakaraBio SMARTer smRNA-Seq Kit on iSeq100 (Illumina). Pre-processing of raw sequencing data, quality control and miRNA differential expression analysis was performed using sRNAtoolbox pipeline. Functional interpretation of differentially expressed miRNA target genes was done in DIANA-miRPathv3.0. Tarbase v8.0 served as a resource of miRNA:gene interactions. Achieved read depth was approximately 1 million raw reads/sample, allowing detection of up to 92 mature miRNAs after genome alignment and miRbase v22 annotation. Differential expression analysis identified the significant upregulation of hsa-miR-23c (log2FC=4.29, Padj= 0.03) in progressive phenotype. Top significantly enriched KEGG pathways in hsa-miR-23c targets suggested regulation of molecular pathways involved in autoimmunity (antigen presentation, Epstein-Barr virus infection) and cancer. In conclusion, this pilot study indicates phenotype-related differences in expression of miRNAs, molecules with high regulatory and biomarker properties. Although detected in PBMC, has-miR-23c is highly expressed in the brain and target MS relevant genes such as, HLA (A, B, C), transferrin receptor, Nrf2, recently proposed to play important role in neurodegeneration.",
journal = "17th World Congress on Controversies in Neurology (CONy) : e-posters",
title = "Insight in miRNome of severe multiple sclerosis: Pilot study of distinctive relapse-onset MS phenotypes",
pages = "427-427",
url = "https://hdl.handle.net/21.15107/rcub_vinar_12641"
}

Stanković, A., Jovanović, I. G., Dinčić, E., Vojinović, S., Stojković, L. S., Đorđević, A., Kuveljić, J.,& Živković, M.. (2023). Insight in miRNome of severe multiple sclerosis: Pilot study of distinctive relapse-onset MS phenotypes. in 17th World Congress on Controversies in Neurology (CONy) : e-posters, 427-427.
https://hdl.handle.net/21.15107/rcub_vinar_12641

Stanković A, Jovanović IG, Dinčić E, Vojinović S, Stojković LS, Đorđević A, Kuveljić J, Živković M. Insight in miRNome of severe multiple sclerosis: Pilot study of distinctive relapse-onset MS phenotypes. in 17th World Congress on Controversies in Neurology (CONy) : e-posters. 2023;:427-427.
https://hdl.handle.net/21.15107/rcub_vinar_12641 .

Stanković, Aleksandra, Jovanović, Ivan G., Dinčić, E., Vojinović, S., Stojković, Ljiljana S., Đorđević, Ana, Kuveljić, Jovana, Živković, Maja, "Insight in miRNome of severe multiple sclerosis: Pilot study of distinctive relapse-onset MS phenotypes" in 17th World Congress on Controversies in Neurology (CONy) : e-posters (2023):427-427,
https://hdl.handle.net/21.15107/rcub_vinar_12641 .

TY  - CONF
AU  - Kuveljić, Jovana
AU  - Životić, Ivan
AU  - Dekleva, Milica
AU  - Živković, Maja
AU  - Đurić, Tamara
PY  - 2023
UR  - https://vinar.vin.bg.ac.rs/handle/123456789/12648
AB  - Introduction: Myocardial infarction (MI) and consequential ischemia with cardiomyocyte loss are followed by left ventricular (LV) remodeling. LV remodeling is crucial process for cardiac function preservation, although when prolonged it can become maladaptive and lead to impaired systolic function and further cardiovascular complications. Echocardiographic parameters are used as a measure of LV structure and function. ADAM17 (a disintegrin and metalloprotease domain) and CDKN1A (cyclindependent kinase inhibitor 1A) have shown regulating role in DNA repair, inflammation, remodeling and fibrosis. The aim of this preliminary study was to investigate the potential effect of CDKN1 and ADAM17 mRNA in post MI heart remodeling. Methods: Sixty four patients with the first MI were prospectively followed-up 6 months after MI. Change (Δ) of echocardiographic parameters within 6 months was calculated as a difference between the value at 6-month follow-up and value at admission. Relative gene expression was detected using the TaqMan® technology. Statistical analyses were done by Statistica 8 software. Results: We have observed correlation between CDKN1A mRNA expression and change of LV enddiastolic diameter (ΔLVEDD, R=0.3, p=0.01) and LV end-systolic diameter (ΔLVESD, R=0.3, p=0.02), but not with LV ejection fraction and stroke volume. ADAM17 expression was not in correlation with analyzed parameters of LV remodeling. However, CDKN1A and ADAM17 mRNA expression in PBMC six months after MI were positively correlated (R=0.6, p<0.001). Conclusion: Preliminary resultssuggest that CDKN1 has a role in post MI LV remodeling, correlating with changes in echocardiographic parameters of LV structure. The validation on a larger sample size is required.
C3  - CoMBoS2 – the Second Congress of Molecular Biologists of Serbia : Book of abstracts
T1  - Correlations of CDKN1A and ADAM17 expression with a change of left ventricular remodeling echocardiographic parameters in PBMC of patients six months after the first myocardial infarction
SP  - 53
EP  - 53
UR  - https://hdl.handle.net/21.15107/rcub_vinar_12648
ER  - 

@conference{
author = "Kuveljić, Jovana and Životić, Ivan and Dekleva, Milica and Živković, Maja and Đurić, Tamara",
year = "2023",
abstract = "Introduction: Myocardial infarction (MI) and consequential ischemia with cardiomyocyte loss are followed by left ventricular (LV) remodeling. LV remodeling is crucial process for cardiac function preservation, although when prolonged it can become maladaptive and lead to impaired systolic function and further cardiovascular complications. Echocardiographic parameters are used as a measure of LV structure and function. ADAM17 (a disintegrin and metalloprotease domain) and CDKN1A (cyclindependent kinase inhibitor 1A) have shown regulating role in DNA repair, inflammation, remodeling and fibrosis. The aim of this preliminary study was to investigate the potential effect of CDKN1 and ADAM17 mRNA in post MI heart remodeling. Methods: Sixty four patients with the first MI were prospectively followed-up 6 months after MI. Change (Δ) of echocardiographic parameters within 6 months was calculated as a difference between the value at 6-month follow-up and value at admission. Relative gene expression was detected using the TaqMan® technology. Statistical analyses were done by Statistica 8 software. Results: We have observed correlation between CDKN1A mRNA expression and change of LV enddiastolic diameter (ΔLVEDD, R=0.3, p=0.01) and LV end-systolic diameter (ΔLVESD, R=0.3, p=0.02), but not with LV ejection fraction and stroke volume. ADAM17 expression was not in correlation with analyzed parameters of LV remodeling. However, CDKN1A and ADAM17 mRNA expression in PBMC six months after MI were positively correlated (R=0.6, p<0.001). Conclusion: Preliminary resultssuggest that CDKN1 has a role in post MI LV remodeling, correlating with changes in echocardiographic parameters of LV structure. The validation on a larger sample size is required.",
journal = "CoMBoS2 – the Second Congress of Molecular Biologists of Serbia : Book of abstracts",
title = "Correlations of CDKN1A and ADAM17 expression with a change of left ventricular remodeling echocardiographic parameters in PBMC of patients six months after the first myocardial infarction",
pages = "53-53",
url = "https://hdl.handle.net/21.15107/rcub_vinar_12648"
}

Kuveljić, J., Životić, I., Dekleva, M., Živković, M.,& Đurić, T.. (2023). Correlations of CDKN1A and ADAM17 expression with a change of left ventricular remodeling echocardiographic parameters in PBMC of patients six months after the first myocardial infarction. in CoMBoS2 – the Second Congress of Molecular Biologists of Serbia : Book of abstracts, 53-53.
https://hdl.handle.net/21.15107/rcub_vinar_12648

Kuveljić J, Životić I, Dekleva M, Živković M, Đurić T. Correlations of CDKN1A and ADAM17 expression with a change of left ventricular remodeling echocardiographic parameters in PBMC of patients six months after the first myocardial infarction. in CoMBoS2 – the Second Congress of Molecular Biologists of Serbia : Book of abstracts. 2023;:53-53.
https://hdl.handle.net/21.15107/rcub_vinar_12648 .

Kuveljić, Jovana, Životić, Ivan, Dekleva, Milica, Živković, Maja, Đurić, Tamara, "Correlations of CDKN1A and ADAM17 expression with a change of left ventricular remodeling echocardiographic parameters in PBMC of patients six months after the first myocardial infarction" in CoMBoS2 – the Second Congress of Molecular Biologists of Serbia : Book of abstracts (2023):53-53,
https://hdl.handle.net/21.15107/rcub_vinar_12648 .

TY  - CONF
AU  - Đorđević, Ana M.
AU  - Dekleva, Milica
AU  - Živković, Maja
AU  - Stanković, Aleksandra
AU  - Kuveljić, Jovana
AU  - Đurić, Tamara
PY  - 2021
UR  - https://vinar.vin.bg.ac.rs/handle/123456789/12729
AB  - After myocardial infarction (MI) and consequential ischemia, the heart undergoes a set of geometric and functional changes. In the early days after injury, these changes, defined as cardiac remodeling, are the powerful factor that preserves cardiac function and promotes survival. However, it may continue for months after MI and eventually lead to adverse remodeling with impaired systolic function and reduced myocardial contractility and further cardiovascular complications, such as heart failure (HF). Left ventricular (LV) ejection fraction (EF) is widely used as an index of systolic function in cardiac patients. However, global myocardial strain has been found to be superior to the conventional parameters, such as LVEF, in terms of assessment of cardiac performance after MI. Galectin-3 (gal-3) is a multifunctional protein involved in a variety of physiological and pathological processes, affecting the entire cardiovascular continuum of MI. Gal-3 is encoded by a LGALS-3 gene, located in a unique, 300 kb long haplotype block in Caucasians. Gal-3 serum level has been approved as a diagnostic marker for risk stratification and prognosis evaluation of HF patients according to the ACC/AHA/HFSA Guideline for the management of HF. The purpose of the present prospective study was to analyze the possible association of tag genetic variants of the haplotype block containing LGALS-3 with changes in cardiac parameters, LVEF and global radial strain (GRS), within 6 months post-MI. The study enrolled 120 patients with first acute MI that were prospectively followed-up 6 months after MI. According to Tagger server, rs4040064 G/T, rs11628437 G/A and rs7159490 C/T variants cover 82% (r2>0.8) of phenotypic variance of the aforementioned haplotype block. Tag variants were detected and genotyped by commercially available assays for allelic discrimination. Echocardiography examinations were performed at admission and 6 months post-MI. Change (Δ) of cardiac parameters was calculated as a difference between the value at 6-month follow-up and baseline value (at admission). The referent haplotype is set by the software for carrying haplotype association analysis and represents the most frequent haplotype in the studied groups. Bonferroni correction for multiple testing was performed and p values <0.025 were considered as statistically significant.We found that, compared to the reference GGC haplotype, GAT haplotype had significantly higher expected phenotypic mean [95% CI] of ΔGRS (3.77 [1.28 - 6.25] vs. −5.34 [−12.69 - 2.01], respectively, p=0.025) and ΔLVEF (0.84 [−1.88 - 3.56] vs. −12.91 [−17.30 - −8.53], respectively, p=0.00001), in the direction of decrease of GRS and LVEF 6 months after MI in patients bearing GAT haplotype. Our findings suggest that GAT haplotype bears the risk for diminished LV transmural contractility and radial systolic function: In order to reach a definitive conclusion, our exploratory results should be further validated on a larger sample
C3  - European Journal of Hear Failure
T1  - LGALS-3 containing haplotype block tag variants in association with cardiac parameters changes within six months after the first acute myocardial infarction
VL  - 23
IS  - Suppl. S2
SP  - 311
EP  - 311
UR  - https://hdl.handle.net/21.15107/rcub_vinar_12729
ER  - 

@conference{
author = "Đorđević, Ana M. and Dekleva, Milica and Živković, Maja and Stanković, Aleksandra and Kuveljić, Jovana and Đurić, Tamara",
year = "2021",
abstract = "After myocardial infarction (MI) and consequential ischemia, the heart undergoes a set of geometric and functional changes. In the early days after injury, these changes, defined as cardiac remodeling, are the powerful factor that preserves cardiac function and promotes survival. However, it may continue for months after MI and eventually lead to adverse remodeling with impaired systolic function and reduced myocardial contractility and further cardiovascular complications, such as heart failure (HF). Left ventricular (LV) ejection fraction (EF) is widely used as an index of systolic function in cardiac patients. However, global myocardial strain has been found to be superior to the conventional parameters, such as LVEF, in terms of assessment of cardiac performance after MI. Galectin-3 (gal-3) is a multifunctional protein involved in a variety of physiological and pathological processes, affecting the entire cardiovascular continuum of MI. Gal-3 is encoded by a LGALS-3 gene, located in a unique, 300 kb long haplotype block in Caucasians. Gal-3 serum level has been approved as a diagnostic marker for risk stratification and prognosis evaluation of HF patients according to the ACC/AHA/HFSA Guideline for the management of HF. The purpose of the present prospective study was to analyze the possible association of tag genetic variants of the haplotype block containing LGALS-3 with changes in cardiac parameters, LVEF and global radial strain (GRS), within 6 months post-MI. The study enrolled 120 patients with first acute MI that were prospectively followed-up 6 months after MI. According to Tagger server, rs4040064 G/T, rs11628437 G/A and rs7159490 C/T variants cover 82% (r2>0.8) of phenotypic variance of the aforementioned haplotype block. Tag variants were detected and genotyped by commercially available assays for allelic discrimination. Echocardiography examinations were performed at admission and 6 months post-MI. Change (Δ) of cardiac parameters was calculated as a difference between the value at 6-month follow-up and baseline value (at admission). The referent haplotype is set by the software for carrying haplotype association analysis and represents the most frequent haplotype in the studied groups. Bonferroni correction for multiple testing was performed and p values <0.025 were considered as statistically significant.We found that, compared to the reference GGC haplotype, GAT haplotype had significantly higher expected phenotypic mean [95% CI] of ΔGRS (3.77 [1.28 - 6.25] vs. −5.34 [−12.69 - 2.01], respectively, p=0.025) and ΔLVEF (0.84 [−1.88 - 3.56] vs. −12.91 [−17.30 - −8.53], respectively, p=0.00001), in the direction of decrease of GRS and LVEF 6 months after MI in patients bearing GAT haplotype. Our findings suggest that GAT haplotype bears the risk for diminished LV transmural contractility and radial systolic function: In order to reach a definitive conclusion, our exploratory results should be further validated on a larger sample",
journal = "European Journal of Hear Failure",
title = "LGALS-3 containing haplotype block tag variants in association with cardiac parameters changes within six months after the first acute myocardial infarction",
volume = "23",
number = "Suppl. S2",
pages = "311-311",
url = "https://hdl.handle.net/21.15107/rcub_vinar_12729"
}

Đorđević, A. M., Dekleva, M., Živković, M., Stanković, A., Kuveljić, J.,& Đurić, T.. (2021). LGALS-3 containing haplotype block tag variants in association with cardiac parameters changes within six months after the first acute myocardial infarction. in European Journal of Hear Failure, 23(Suppl. S2), 311-311.
https://hdl.handle.net/21.15107/rcub_vinar_12729

Đorđević AM, Dekleva M, Živković M, Stanković A, Kuveljić J, Đurić T. LGALS-3 containing haplotype block tag variants in association with cardiac parameters changes within six months after the first acute myocardial infarction. in European Journal of Hear Failure. 2021;23(Suppl. S2):311-311.
https://hdl.handle.net/21.15107/rcub_vinar_12729 .

Đorđević, Ana M., Dekleva, Milica, Živković, Maja, Stanković, Aleksandra, Kuveljić, Jovana, Đurić, Tamara, "LGALS-3 containing haplotype block tag variants in association with cardiac parameters changes within six months after the first acute myocardial infarction" in European Journal of Hear Failure, 23, no. Suppl. S2 (2021):311-311,
https://hdl.handle.net/21.15107/rcub_vinar_12729 .

TY  - CONF
AU  - Đorđević, Ana
AU  - Živković, Maja
AU  - Dekleva, Milica
AU  - Marković-Nikolić, N.
AU  - Kuveljić, Jovana
AU  - Stanković, Aleksandra
AU  - Đurić, Tamara
PY  - 2014
UR  - https://vinar.vin.bg.ac.rs/handle/123456789/12807
PB  - Belgrade : Serbian Physiological Society
C3  - 3rd Congress of physiological sciences of Serbia "Molecular, cellular and integrative basis of health and disease: Transdisciplinary approach" : Abstract book
T1  - Matrix metalloproteinase-1 and matrix metalloproteinase-3 promoter gene polumorphisms in left ventricular remodeling after first myocardial infarction: preliminary results
SP  - 110
EP  - 110
UR  - https://hdl.handle.net/21.15107/rcub_vinar_12807
ER  - 

@conference{
author = "Đorđević, Ana and Živković, Maja and Dekleva, Milica and Marković-Nikolić, N. and Kuveljić, Jovana and Stanković, Aleksandra and Đurić, Tamara",
year = "2014",
publisher = "Belgrade : Serbian Physiological Society",
journal = "3rd Congress of physiological sciences of Serbia "Molecular, cellular and integrative basis of health and disease: Transdisciplinary approach" : Abstract book",
title = "Matrix metalloproteinase-1 and matrix metalloproteinase-3 promoter gene polumorphisms in left ventricular remodeling after first myocardial infarction: preliminary results",
pages = "110-110",
url = "https://hdl.handle.net/21.15107/rcub_vinar_12807"
}

Đorđević, A., Živković, M., Dekleva, M., Marković-Nikolić, N., Kuveljić, J., Stanković, A.,& Đurić, T.. (2014). Matrix metalloproteinase-1 and matrix metalloproteinase-3 promoter gene polumorphisms in left ventricular remodeling after first myocardial infarction: preliminary results. in 3rd Congress of physiological sciences of Serbia "Molecular, cellular and integrative basis of health and disease: Transdisciplinary approach" : Abstract book
Belgrade : Serbian Physiological Society., 110-110.
https://hdl.handle.net/21.15107/rcub_vinar_12807

Đorđević A, Živković M, Dekleva M, Marković-Nikolić N, Kuveljić J, Stanković A, Đurić T. Matrix metalloproteinase-1 and matrix metalloproteinase-3 promoter gene polumorphisms in left ventricular remodeling after first myocardial infarction: preliminary results. in 3rd Congress of physiological sciences of Serbia "Molecular, cellular and integrative basis of health and disease: Transdisciplinary approach" : Abstract book. 2014;:110-110.
https://hdl.handle.net/21.15107/rcub_vinar_12807 .

Đorđević, Ana, Živković, Maja, Dekleva, Milica, Marković-Nikolić, N., Kuveljić, Jovana, Stanković, Aleksandra, Đurić, Tamara, "Matrix metalloproteinase-1 and matrix metalloproteinase-3 promoter gene polumorphisms in left ventricular remodeling after first myocardial infarction: preliminary results" in 3rd Congress of physiological sciences of Serbia "Molecular, cellular and integrative basis of health and disease: Transdisciplinary approach" : Abstract book (2014):110-110,
https://hdl.handle.net/21.15107/rcub_vinar_12807 .